SCHEMBL13508087

SCHEMBL13508087

c1ccc2c(-c3c4ccccc4c(-c4ccc5c(c4)oc4c6oc7cc(-c8c9ccccc9c(-c9cccc%10ccccc9%10)c9ccccc89)ccc7c6c6ccccc6c54)c4ccccc34)cccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSD A5PKW4 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.36
▸ HSD17B10 Q99714 3/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ ALOX5 P09917 1/20 0.36
▸ HPGD P15428 2/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ TSHR P16473 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ ESR1 P03372 1/20 0.35
▸ ESR2 Q92731 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13508207 0.95 ALDH1A1 (0.36) PSDALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL16067736 0.95 PSD (0.38) PSDALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL17944787 0.91 ALOX5 (0.38) PSDALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL16067933 0.91 PSD (0.36) PSDALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL19108549 0.91 ALOX5 (0.40) PSDALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL13507283 0.90 PSD (0.40) PSDALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL17944568 0.90 CYP1A1 (0.36) PSDALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL17931939 0.90 PSD (0.37) PSDALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL24341252 0.89 ALOX5 (0.43) PSDALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL20053387 0.89 PSD (0.35) PSDALDH1A1HSD17B10KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed
EP-2145936-A2 Fluorene and pyrene derivatives and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-01-20 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 PSD 4194/4885ALDH1A1 119/4885HSD17B10 1287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback